- (a) Specifications. Each milliliter of solution contains 60 milligrams (mg) clodronate disodium.
- (b) Sponsor. See No. 043264 in § 510.600(c) of this chapter.
- (c) Conditions of use in horses—(1) Amount. Administer 1.8 mg per kilogram of body weight by intramuscular injection up to a maximum dose of 900 mg per horse.
- (2) Indications for use. For the control of clinical signs associated with navicular syndrome.
- (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 37620, July 2, 2014]